UNSPSC 51162326: Acetaminophen/pseudoephedrine/triprolidine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162326 Acetaminophen/pseudoephedrine/triprolidine is a Commodity code that does not align with the recent state and local contract opportunities posted under this classification. The two recent solicitations recovered show procurement activity for naloxone and safe drug deactivation systems (Seminole County, Florida) and generic multi-source pharmaceuticals and over-the-counter products through a multistate cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance), neither of which centers on the specific combination product named in the code. The mismatch suggests that either the opportunities were mistagged with this code or that state and local buyers are not currently sourcing this particular drug combination through formal procurement channels at a detectable scale.

The Seminole County opportunity (IFB 60459723LAS, response due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Minnesota Department of Administration's MMCAP RFP (S1070000015802, response due March 26, 2026) established multistate contracts for generic pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon through three authorized wholesalers. No recent opportunity explicitly sources acetaminophen/pseudoephedrine/triprolidine combinations. Prospective vendors should verify whether this code continues to reflect active state and local demand or whether opportunities are being tagged with higher-level pharmaceutical family or class codes instead.